ENCePP web header
ENCePP web header
  • Ruthsarian
  • Home
  • Sitemap
  • Q & A
  • Notice Board
    • PhEpi & PhV activities
    • Research Funding
    • Conferences & meetings
    • Recruitment
  • Links
  • Contact Us

Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Assessment of the prophylactic effect of chloroquine/hydroxychloroquine on the COVID-19 hospitalization and mortality risk in patients with rheumatic diseases: a large-scale Italian nested case-control study Dr Stefania Spila Alegiani 23/11/2020
Finalised Association of ACE inhibitors and AT1R blockers and prognosis in hospitalized COVID-19 patients: a cohort study in Italy Dr Stefania Spila Alegiani 11/05/2020
Planned Time to treatment intensification in patients receiving metformin+incretin-based medicines versus metformin+other hypoglicemics Dr Roberto Giuseppe 14/02/2019

  • News
  • About Us
  • ENCePP Documents
  • Training in PhEpi and PV

  • Code of Conduct
  • Standards & Guidances
  • ENCePP Study Seal
  • Public Consultation
  • Glossary of terms

  • Resources Database

  • Partners forum

  • EU PAS Register

  • About EU PAS Register
© 1995-2020 European Medicines Agency | Contact Us | Privacy Policy | Admin Login | Disclaimer

As of 1.2.2020, the UK is no longer an EU Member State. However, EU law still applies to the UK during the transition period.


combined emea eu logo European Medicines Agency Europa Website
Version: 4.4.1.1